Cervical lymph node metastasis of neuroendocrine carcinoma of unknown primary origin: a rare case report and review of the literature
- 1ENT Head and Neck Surgery Department, Salah Azaiz Institute, Tunis, Tunisia
- 2Pathology Department, Salah Azaiz Institute, Tunis, Tunisia
Abstract
Introduction and importance:: Cervical lymph node metastases from a neuroendocrine carcinoma (NEC) of unknown primary origin represent an exceptionally rare clinical entity, accounting for only 3%–5% of all carcinomas of unknown primary origin. Due to their aggressive biological behavior and the absence of standardized clinical guidelines, they pose significant diagnostic and therapeutic dilemmas.
Presentation of case:: A 28-year-old male with unremarkable medical, family, and social histories presented with a rapidly growing, painless, right-sided neck swelling of 8 months' duration. Fine-needle aspiration cytology was inconclusive. A diagnostic adenectomy suggested a poorly differentiated neuroendocrine neoplasm. Extensive whole-body imaging, including a CT scan, an OctreoScan, and subsequent upper and lower gastrointestinal endoscopies, failed to reveal a primary source. The patient underwent a right-sided radical neck dissection due to extensive local infiltration, followed by adjuvant chemotherapy consisting of cisplatin and etoposide. At the 12-month follow-up, the patient remains in complete clinical and radiological remission.
Clinical discussion:: High-grade (grade III) cervical NECs require systematic exclusion of primary tumors, particularly from the bronchopulmonary tract, gastrointestinal tract, and thyroid gland. Immunohistochemical profiling is paramount; our case demonstrated positivity for synaptophysin, chromogranin, and CD56, with a Ki-67 index of 40%. Management must be aggressive and multidisciplinary, combining radical surgical clearance with platinum-based systemic chemotherapy to optimize locoregional control.
Conclusion:: Cervical high-grade NEC of unknown primary origin requires an exhaustive diagnostic workup and immunohistochemical evaluation. Early management via radical surgical resection and adjuvant systemic chemotherapy offers favorable locoregional control and survival outcomes.
Related
- Intracranial metastasis following intrahepatic remission in primary hepatic small cell neuroendocrine carcinoma: a case report
- Mucosal Small Cell Neuroendocrine Carcinoma of the Gallbladder With Extraregional Lymph Node Metastasis: A Case Report
- Two cases of large cell neuroendocrine carcinoma of the gallbladder: case reports and systemic literature review
- Treatment strategies for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis: a narrative review
- Peritoneal neuroendocrine carcinoma of unknown primary with markedly elevated alpha-fetoprotein: a case report
BibTeX
@article{methnani2026cervical,
title = {{Cervical lymph node metastasis of neuroendocrine carcinoma of unknown primary origin: a rare case report and review of the literature}},
author = {Alia Methnani and Lina Jeridi and Ameni Amri and Yoldez Houcine and Skander Kedous and Sawssen Dhambri},
journal = {International Journal of Surgery Case Reports},
year = {2026},
month = sep,
doi = {10.1097/rc9.0000000000000834},
url = {https://doi.org/10.1097/rc9.0000000000000834},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Cervical lymph node metastasis of neuroendocrine carcinoma of unknown primary origin: a rare case report and review of the literature
AU - Alia Methnani
AU - Lina Jeridi
AU - Ameni Amri
AU - Yoldez Houcine
AU - Skander Kedous
AU - Sawssen Dhambri
PY - 2026
DA - 2026/09/21
JO - International Journal of Surgery Case Reports
DO - 10.1097/rc9.0000000000000834
UR - https://doi.org/10.1097/rc9.0000000000000834
AB - Introduction and importance:: Cervical lymph node metastases from a neuroendocrine carcinoma (NEC) of unknown primary origin represent an exceptionally rare clinical entity, accounting for only 3%–5% of all carcinomas of unknown primary origin. Due to their aggressive biological behavior and the absence of standardized clinical guidelines, they pose significant diagnostic and therapeutic dilemmas. Presentation of case:: A 28-year-old male with unremarkable medical, family, and social histories presented with a rapidly growing, painless, right-sided neck swelling of 8 months' duration. Fine-needle aspiration cytology was inconclusive. A diagnostic adenectomy suggested a poorly differentiated neuroendocrine neoplasm. Extensive whole-body imaging, including a CT scan, an OctreoScan, and subsequent upper and lower gastrointestinal endoscopies, failed to reveal a primary source. The patient underwent a right-sided radical neck dissection due to extensive local infiltration, followed by adjuvant chemotherapy consisting of cisplatin and etoposide. At the 12-month follow-up, the patient remains in complete clinical and radiological remission. Clinical discussion:: High-grade (grade III) cervical NECs require systematic exclusion of primary tumors, particularly from the bronchopulmonary tract, gastrointestinal tract, and thyroid gland. Immunohistochemical profiling is paramount; our case demonstrated positivity for synaptophysin, chromogranin, and CD56, with a Ki-67 index of 40%. Management must be aggressive and multidisciplinary, combining radical surgical clearance with platinum-based systemic chemotherapy to optimize locoregional control. Conclusion:: Cervical high-grade NEC of unknown primary origin requires an exhaustive diagnostic workup and immunohistochemical evaluation. Early management via radical surgical resection and adjuvant systemic chemotherapy offers favorable locoregional control and survival outcomes.
SN - 2210-2612
ER -